Skip to Content
You are currently on the new version of our website. Access the old version .

International Journal of Neonatal Screening, Volume 9, Issue 2

2023 June - 18 articles

Cover Story: A number of problems emerged at the start of the COVID-19 pandemic. Newborn screening (NBS) programs, although being a vital public health service, also faced staff and essential supply shortages. All processes in NBS had to be re-evaluated to ensure safe blood collection, transportation, analysis and result communication. Telemedicine gained attention to enable communication with patients, parents, and medical staff. Despite these difficulties, with adaptations, modifications and contingency planning, some centres continued NBS with minimal problems or even implemented novel NBS protocols for the inclusion of additional diseases. National and international collaborations are important to learn and to improve NBS programs during a time of crisis and also in regular daily practice. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (18)

  • Article
  • Open Access
10 Citations
4,873 Views
9 Pages

Screening newborns for congenital cytomegalovirus (cCMV) infection is critical for early detection and prompt diagnosis of related long-term consequences of infection, such as sensorineural hearing loss and neurodevelopmental delays. The objective of...

  • Technical Note
  • Open Access
1 Citations
2,842 Views
6 Pages

Mucopolysaccharidosis type II (MPS-II, Hunter syndrome, OMIM:30990) is a lysosomal storage disorder (LSD) that results in iduronate 2-sulphatase (I2S) enzyme deficiency. MPS-II was added to the Recommended Uniform Screening Panel (RUSP) in August 202...

  • Review
  • Open Access
27 Citations
5,450 Views
17 Pages

Newborn Screening for Fabry Disease: Current Status of Knowledge

  • Vincenza Gragnaniello,
  • Alessandro P. Burlina,
  • Anna Commone,
  • Daniela Gueraldi,
  • Andrea Puma,
  • Elena Porcù,
  • Maria Stornaiuolo,
  • Chiara Cazzorla and
  • Alberto B. Burlina

Fabry disease is an X-linked progressive lysosomal disorder, due to α-galactosidase A deficiency. Patients with a classic phenotype usually present in childhood as a multisystemic disease. Patients presenting with the later onset subtypes have...

  • Review
  • Open Access
14 Citations
3,804 Views
13 Pages

Caring for a child with congenital cytomegalovirus (cCMV) can be costly for families, not only in terms of out-of-pocket expenses, but also in terms of caregiver time, relationships, career trajectories, and mental health. These additional burdens ar...

  • Article
  • Open Access
14 Citations
3,645 Views
11 Pages

Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation

  • Kristina Mikhalchuk,
  • Olga Shchagina,
  • Alena Chukhrova,
  • Viktoria Zabnenkova,
  • Polina Chausova,
  • Nina Ryadninskaya,
  • Dmitry Vlodavets,
  • Sergei I. Kutsev and
  • Alexander Polyakov

5q spinal muscular atrophy (5q SMA) is one of the most common autosomal recessive disorders in the Russian Federation. The first medication to treat 5q SMA was registered in the Russian Federation for treatment of all 5q SMA types in 2019, and the la...

  • Article
  • Open Access
3 Citations
3,066 Views
16 Pages

Implementation of Newborn Hearing Screening in Albania

  • Andrea M. L. Bussé,
  • Birkena Qirjazi,
  • Allison R. Mackey,
  • Jan Kik,
  • André Goedegebure,
  • Hans L. J. Hoeve,
  • Ervin Toçi,
  • Enver Roshi,
  • Gwen Carr and
  • Huibert J. Simonsz
  • + 1 author

Newborn hearing screening (NHS) was implemented in Albania in four maternity hospitals in 2018 and 2019. Implementation outcome, screening outcome, and screening quality measures were evaluated. Infants were first screened by midwives and nurses befo...

  • Article
  • Open Access
9 Citations
3,438 Views
19 Pages

Neonatal screening has excellent coverage in France. Data from the foreign literature raise questions about the informed consent to this screening. The Neonatal Screening and Informed Consent Dépistage Néonatal Information et Consenteme...

  • Article
  • Open Access
9 Citations
4,267 Views
11 Pages

Parental Awareness, Knowledge, and Attitudes Regarding Current and Future Newborn Bloodspot Screening: The First Report from Thailand

  • Kalyarat Wilaiwongsathien,
  • Duangrurdee Wattanasirichaigoon,
  • Sasivimol Rattanasiri,
  • Chanatpon Aonnuam,
  • Chayada Tangshewinsirikul and
  • Thipwimol Tim-Aroon

Newborn screening (NBS) is a public health service that is used to screen for treatable conditions in many countries, including Thailand. Several reports have revealed low levels of parental awareness and knowledge about NBS. Because of limited data...

  • Case Report
  • Open Access
2 Citations
2,452 Views
6 Pages

Foetal Haemoglobin as a Marker of Bone Marrow Suppression Secondary to Anti-Kell Alloimmunisation

  • Rodrigo Alfredo Morales Painamil,
  • José Manuel González de Aledo-Castillo,
  • Marta Teresa-Palacio,
  • Ana Argudo-Ramírez,
  • Rosa M. López-Galera,
  • Abraham J. Paredes-Fuentes,
  • Victoria Aldecoa-Bilbao and
  • Miguel Alsina-Casanova

Anti-Kell alloimmunisation is a potentially severe minor blood group type incompatibility, not only as a cause of haemolytic disease of the foetus and newborn, but also due to the destruction of red blood cells (RBC) and mature form in the bone marro...

  • Article
  • Open Access
13 Citations
4,694 Views
9 Pages

Newborn screening (NBS) is a state or territory-based public health system that screens newborns for congenital diseases that typically do not present with clinical symptoms at birth but can cause significant mortality and morbidity if not detected o...

  • Opinion
  • Open Access
19 Citations
4,141 Views
16 Pages

Inborn errors of immunity (IEI) are a group of over 450 genetically distinct conditions associated with significant morbidity and mortality, for which early diagnosis and treatment improve outcomes. Newborn screening for severe combined immunodeficie...

  • Review
  • Open Access
3 Citations
4,543 Views
11 Pages

Newborn Screening in a Pandemic—Lessons Learned

  • Matej Mlinaric,
  • James R. Bonham,
  • Viktor Kožich,
  • Stefan Kölker,
  • Ondrej Majek,
  • Tadej Battelino,
  • Ana Drole Torkar,
  • Vanesa Koracin,
  • Dasa Perko and
  • Urh Groselj
  • + 5 authors

The COVID-19 pandemic affected many essential aspects of public health, including newborn screening programs (NBS). Centers reported missing cases of inherited metabolic disease as a consequence of decreased diagnostic process quality during the pand...

  • Review
  • Open Access
21 Citations
4,915 Views
8 Pages

Implementation of Newborn Screening for Conditions in the United States First Recommended during 2010–2018

  • Sikha Singh,
  • Jelili Ojodu,
  • Alex R. Kemper,
  • Wendy K. K. Lam and
  • Scott D. Grosse

The Recommended Uniform Screening Panel (RUSP) is the list of conditions recommended by the US Secretary of Health and Human Services for inclusion in state newborn screening (NBS). During 2010–2022, seven conditions were added to the RUSP: sev...

  • Article
  • Open Access
6 Citations
10,632 Views
15 Pages

Newborn Screening (NBS) saves babies from mental retardation and death. In the Philippines, it was formally established by law in 2004. Program success requires physicians, nurses, and midwives to educate and motivate parents. The COVID-19 pandemic r...

  • Article
  • Open Access
3 Citations
5,020 Views
11 Pages

Secondary Reporting of G6PD Deficiency on Newborn Screening

  • Stephanie C. Hoang,
  • Pamela Blumenschein,
  • Margaret Lilley,
  • Larissa Olshaski,
  • Aisha Bruce,
  • Nicola A. M. Wright,
  • Ross Ridsdale and
  • Susan Christian

In April 2019, the Alberta Newborn Screening Program expanded to include screening for classic galactosemia using a two-tier screening approach. This approach secondarily identifies infants with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Th...

  • Article
  • Open Access
10 Citations
3,237 Views
13 Pages

Congenital cytomegalovirus (cCMV) continues to be a major public health care issue due to its high prevalence throughout the world. However, there is a paucity of studies evaluating how providers manage this infection. This study surveyed North Ameri...

  • Case Report
  • Open Access
2 Citations
2,613 Views
5 Pages

Newborn screening for congenital hypothyroidism (CH) has dramatically improved the neurocognitive outcomes for newborns with a confirmed positive screening test result. However, screening yields a small number of false positive and false negative res...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Int. J. Neonatal Screen. - ISSN 2409-515X